{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:56:53Z","timestamp":1769057813287,"version":"3.49.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"DOI":"10.7759\/cureus.101986","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:46:56Z","timestamp":1769003216000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery"],"prefix":"10.7759","author":[{"given":"Yogeeta","family":"Gunasagran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Cancer Research UK. Uterine cancer incidence statistics. (2025). Accessed: January 21, 2026: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer\/incid...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv484","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"27","author":"Colombo N","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, et al.. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016, 27:16-41. 10.1093\/annonc\/mdv484","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek JS","year":"2023","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C, et al.. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. 2023, 162:383-94. 10.1002\/ijgo.14923","journal-title":"Int J Gynaecol Obstet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100887","article-title":"Neoadjuvant chemotherapy for advanced stage endometrial cancer: a systematic review","volume":"38","author":"Huang AB","year":"2021","unstructured":"Huang AB, Wu J, Chen L, et al.. Neoadjuvant chemotherapy for advanced stage endometrial cancer: a systematic review. Gynecol Oncol Rep. 2021, 38:100887. 10.1016\/j.gore.2021.100887","journal-title":"Gynecol Oncol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605157","article-title":"Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?","volume":"101","author":"Vandenput I","year":"2009","unstructured":"Vandenput I, Van Calster B, Capoen A, et al.. Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?. Br J Cancer. 2009, 101:244-9. 10.1038\/sj.bjc.6605157","journal-title":"Br J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100725","article-title":"The use of neoadjuvant chemotherapy in advanced endometrial cancer","volume":"36","author":"Philp L","year":"2021","unstructured":"Philp L, Kanbergs A, Laurent JS, Growdon WB, Feltmate C, Goodman A. The use of neoadjuvant chemotherapy in advanced endometrial cancer. Gynecol Oncol Rep. 2021, 36:100725. 10.1016\/j.gore.2021.100725","journal-title":"Gynecol Oncol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin N","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, et al.. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021, 31:12-39. 10.1136\/ijgc-2020-002230","journal-title":"Int J Gynecol Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2018-000033","article-title":"A novel prediction method for lymph node involvement in endometrial cancer: machine learning","volume":"29","author":"G\u00fcnakan E","year":"2019","unstructured":"G\u00fcnakan E, Atan S, Haberal AN, K\u00fc\u00e7\u00fcky\u0131ld\u0131z \u0130A, G\u00f6k\u00e7e E, Ayhan A. A novel prediction method for lymph node involvement in endometrial cancer: machine learning. Int J Gynecol Cancer. 2019, 29:320-4. 10.1136\/ijgc-2018-000033","journal-title":"Int J Gynecol Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456951-management-of-suspected-stage-iva-endometrial-cancer-with-rectosigmoid-involvement-using-neoadjuvant-chemotherapy-and-interval-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:46:57Z","timestamp":1769003217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456951-management-of-suspected-stage-iva-endometrial-cancer-with-rectosigmoid-involvement-using-neoadjuvant-chemotherapy-and-interval-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.101986","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,21]]}}}